The economics of the 10-yr ISRG JV are not great as many have learned - ISRG got a sweetheart deal - not much more than OEM cost for the Firefly equip and $200-250 to NVDQ on consumables. Nothing like what NVDQ makes going direct or w/ KCI/Lifecell. That said, benefit is the technology gets widely distributed and surgeons get familiarity with it for use in SPYElite + Pinpoint which is great.
How solid are your numbers on "cost for the Firefly equipment" and consumables? I haven't been able to find them anywhere. Also the "10-year" deal started when and is there any covenant to renegotiate shared compensation at its close? You are the first one who seems to have access to this information. Thanks for posting it and I look forward to any further revelations/discussions on the details.
OEM and consummable terms of ISRG deal are avail from analyst reports and from the co. They are 2+ yrs into a 10-yr agreement with ISRG. Dont believe terms are renegotiable, but not 100% on that. Deal is certainly profitable but not hugely so on OEM side and $200-250 on kits. But the benefit of the tech being validated by ISRG, widely distributed and gaining familiarity with surgeons/hospitals is incalculable, plus ISRG will eventually have to re-up given how integral Firefly is becoming to DaVinci.